Zobrazeno 1 - 10
of 52
pro vyhledávání: '"J. D. Iglehart"'
Publikováno v:
Oncogene. 18:6000-6012
The hereditary breast cancer susceptibility gene, BRCA2, is considered to be a tumor suppressor gene that may be involved in the cellular response to DNA damage. The transcript for this gene is cell cycle regulated with mRNA levels reaching a peak ju
Autor:
Prema S. Rao, E. Trogan, Alice C. Coogan, Christopher D. Kontos, Kevin G. Peters, Jeffrey R. Marks, Sabita Sankar, Donald A. Berry, J. D. Iglehart
Publikováno v:
British Journal of Cancer
Endothelial receptor tyrosine kinases may play important roles in pathological vascular growth, particularly in tumours. In this study, immunohistochemistry was used to evaluate the expression of a novel endothelial receptor tyrosine kinase, Tie2/Tek
Publikováno v:
Radiology. 203:159-163
To evaluate whether an artificial neural network (ANN) can predict breast cancer invasion on the basis of readily available medical findings (ie, mammographic findings classified according to the American College of Radiology Breast Imaging Reporting
Autor:
C. Aleman, Jeffrey R. Marks, J. D. Iglehart, Prescott L. Deininger, Donald P. McDonnell, John D. Norris, P. A. Futreal, Roger W. Wiseman, Daju Fan
Publikováno v:
Journal of Biological Chemistry. 270:22777-22782
We have utilized a genetic selection system in yeast to identify novel estrogen-responsive genes within the human genome and to define the sequences in the BRCA-1 gene responsible for its estrogen responsiveness. This approach led to the identificati
Autor:
Randy L. Jirtle, Tadashi Murase, Mitchell S. Anscher, Barbara Abbott, J. D. Iglehart, Feng Ming Kong
Publikováno v:
Annals of Surgery. 222:155-162
OBJECTIVE: The authors determined whether untreated breast cancer patients have elevated plasma levels of transforming growth factor-beta 1 (TGF-beta 1). SUMMARY BACKGROUND DATA: Increased plasma TGF-beta 1 levels recently were found after chemothera
Publikováno v:
Breast Cancer Research and Treatment. 34:253-263
Ductal carcinoma in situ (intraductal carcinoma) of the breast is a commonly recognized and curable clinical entity. Patients with intraductal carcinoma are at risk to develop invasive breast cancer presumably due to a transition from the noninvasive
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(6)
ErbB2 (HER-2) gene amplification and overexpression have been shown to predict a better outcome with doxorubicin-based chemotherapy as opposed to alkylator-based chemotherapy in early stage breast cancer. To understand the mechanism of differential r
Publikováno v:
Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 11(2)
Estrogen acts to promote DNA synthesis in the MCF-7 human breast cancer cell line via its interaction with high levels of estrogen receptor. The primary mode of estrogen action has been considered to be through transcriptional activation of genes con
Autor:
S, Clark, J D, Iglehart
Publikováno v:
Advances in surgery. 33
Autor:
J. D. Iglehart
During the preceding year, the Duke Breast Cancer Tissue Repository collected breast cancer tissue from 126 patients undergoing surgery for a primary breast cancer. This compares to 124 entries in the first year of the repository. As before, nearly a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d9a2f72ab250bbc5902a21e082caee
https://doi.org/10.21236/ada391113
https://doi.org/10.21236/ada391113